Amphetamine Salt Process Without Distillation Yield Loss

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing amphetamine synthesis processes face challenges such as the presence of genotoxic impurities, stereo-defined amine centers prone to racemization, toxic and flammable intermediates, and yield loss due to distillation, which are costly and unsafe to handle.

Innovation Solution

A non-distillative process that converts highly pure phosphoramidate compounds to amphetamine sulfate in organic alcohol and directly salts out the amphetamine salt, ensuring high yield, selectivity, and safety.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If fractional distillation is used to reduce impurities, then purity of amphetamine product is improved, but the process becomes difficult and time-consuming due to extremely small boiling point difference between cis/trans mixture of 2-methyl-3-phenylaziridine and dextroamphetamine

Engineering Contradiction:
Improvepurity of amphetamine productVSAvoiddistillation time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent extracts and removes the problematic aziridine impurities through selective chemical reactions and filtration processes before the final product formation, rather than attempting to separate them from the final amphetamine product through time-consuming distillation. This extraction approach eliminates the need for prolonged distillation while achieving high purity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the chemical parameters of the impurity removal process by using selective reagents that react with aziridine impurities under specific conditions, transforming the impurities into removable forms. This parameter change allows for efficient impurity removal without requiring extensive distillation time.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If stereospecific methods are used to prevent racemization, then stereochemical purity is improved, but process cost and complexity increase due to requirements for coupling agents and cold temperature maintenance

Engineering Contradiction:
Improvestereochemical purityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent employs readily available, inexpensive reagents and standard laboratory equipment rather than requiring specialized coupling agents and complex temperature control systems. The method uses common chemical reagents that can be easily handled without sophisticated apparatus, thereby reducing process complexity while maintaining stereochemical integrity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The reaction conditions and reagent selection in the patent are designed to inherently prevent racemization through self-stabilizing mechanisms, eliminating the need for external temperature control systems and complex monitoring equipment. The chemical system itself maintains stereochemical purity without requiring additional complexity.

Inventive Principle:
Principle #25Self-service

3Productivity

If conventional amphetamine synthesis processes are used, then production capacity is achieved, but genotoxic impurities (cis and trans isomers of 2-methyl-3-phenylaziridine) are produced at identifiable and measurable quantities

Engineering Contradiction:
Improveproduction capacityVSAvoidgenotoxic impurities
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent converts the potentially harmful aziridine intermediates into beneficial removable by-products through selective chemical transformations. The impurities are chemically modified into forms that can be easily separated and removed, transforming a harmful presence into a manageable and eliminable component of the process.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent introduces intermediary chemical reagents and processing steps that selectively interact with aziridine impurities, mediating their removal from the reaction mixture. These intermediary substances facilitate the separation and elimination of genotoxic impurities while preserving the desired amphetamine product.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Manufacturing precision

If distillation is used for concentration and purification, then purity is improved, but yield is reduced due to material loss

Engineering Contradiction:
Improvepurity of amphetamine saltVSAvoidyield of amphetamine
Core Design Contradiction:
Manufacturing precisionVSLoss of substance

Solution Approach 1:

The patent extracts and removes impurities through selective chemical reactions and filtration processes that occur before the final product isolation, eliminating the need for yield-reducing distillation steps. This extraction approach achieves high purity while preserving maximum product yield.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the purification approach from thermal distillation to chemical separation methods that operate under milder conditions, preventing product degradation and loss. The parameter change from heat-based to chemistry-based separation maintains both purity and yield.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process achieves high-purity amphetamine salts with reduced impurities, improved safety, and economic efficiency, suitable for pharmaceutical formulations.

Implementation Method 1

converting a highly pure (99.+% pure) phosphoramidate compound to an amphetamine sulfate compound

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

concentrating the amphetamine sulfate compound in a C1 to C5 organic alcohol, and then salting out the high purity amphetamine sulfate salt directly

Methodology Applied
Scientific EffectSalting out: Precipitation

Data Source

PatentUS12534428B2Non-distillative process for manufacturing high purity amphetamines
Publication Date: 2026.01.27 PHARMAPOTHECA A INC
  • US12534428B2 patent drawing
  • US12534428B2 patent drawing
  • US12534428B2 patent drawing

AI summary

The invention provides a non-distillative process for manufacturing amphetamine and substituted amphetamines, comprising obtaining a highly pure phosphoramidate compound, converting the highly pure phosphoramidate compound to an amphetamine sulfate compound, concentrating the amphetamine sulfate compound in isopropanol, and then salting out the amphetamine compound directly to obtain an amphetamine salt, the amphetamine salt selected from amphetamine saccharate, amphetamine sulfate, amphetamine aspartate, alkyl-amphetamine saccharate, alkyl-amphetamine sulfate, alkyl-amphetamine aspartate, aryl-amphetamine saccharate, aryl-amphetamine sulfate, aryl-amphetamine aspartate, and mixtures thereof.